Interaction of ABC Multidrug Transporters with Anticancer Protein Kinase Inhibitors: Substrates and/or Inhibitors?
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
252-272
Author(s):
Csilla Ozvegy-Laczka, Csilla Hegedus, Gergely Szakacs and Balazs Sarkadi
Apoptotic Signaling in Pancreatic Cancer – Therapeutic Application (Supplemental Data)
Journal:
Current Cancer Therapy Reviews
Volume:
5
Page:
122-133
Author(s):
Felix Ruckert, Christian Pilarsky, Hans-Detlev Saeger and Robert Grutzmann
The Role of the Gastrointestinal Microbiota in Colorectal Cancer
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
1524-1527
Author(s):
Ian R. Rowland
Targeting Stem Cells-Clinical Implications for Cancer Therapy
Journal:
Current Stem Cell Research & Therapy
Volume:
4
Page:
147-153
Author(s):
Lan Chun Tu, Greg Foltz, Edward Lin, Leroy Hood and Qiang Tian
Using Pharmacologic Data to Plan Clinical Treatments for Patients with Peritoneal Surface Malignancy
Journal:
Current Drug Discovery Technologies
Volume:
6
Page:
72-81
Author(s):
Kurt Van der Speeten, Oswald Anthony Stuart and Paul H. Sugarbaker
Molecular Markers for Individualized Therapy in Colorectal Cancer: Progress Towards a Pharmacogenomics Array
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
7
Page:
70-80
Author(s):
S. Ahn, F. Hussain and T. Dragovich
Molecular Targets for Epigenetic Therapy of Cancer
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
161-165
Author(s):
Rita Humeniuk, Prasun J. Mishra, Joseph R. Bertino and Debabrata Banerjee
Targeting Histone Deacetylases in Neuroblastoma
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
436-447
Author(s):
O. Witt, H. E. Deubzer, M. Lodrini, T. Milde and I. Oehme
Importance and Limitations of Chemotherapy Among the Available Treatments for Gastrointestinal Tumours
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
162-184
Author(s):
Jose J.G. Marin, Marta R. Romero, Alba G. Blazquez, Elisa Herraez, Emma Keck and Oscar Briz
Role of Tyrosine Phosphatase Inhibitors in Cancer Treatment with Emphasis on SH2 Domain-Containing Tyrosine Phosphatases (SHPs)
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
212-220
Author(s):
Mahban Irandoust, Timo K. van den Berg, Gertjan J.L. Kaspers and Jacqueline Cloos